What is OGN's five-year median EV/EBITDA?

8.8x. Half of OGN's weekly readings since May 2022 were higher and half were lower. This page has 240 weekly readings, from Mar 21, 2022 to Oct 19, 2026.

Does a low historical rank mean a stock is a buy?

No. The rank compares OGN only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

Organon & Co (OGN) valuation history

Health Care

$13.75

Latest weekly close · Market cap $3.7B

Above its usual range

As of Oct 24, 2026

OGN's EV/EBITDA of 10.0x is higher than 88% of its weekly readings since May 2022.

Weekly EV/EBITDA since May 2022

EV/EBITDA each weekMiddle half of its readingsMedian 8.8×

Median: 8.8×
Low to high: 7.3×–10.6×
Versus median: +13%
History starts: May 2022

EV/EBITDA

88thpercentile

of its weekly readings since May 2022

Above its usual range

Growth, last 12 months vs the year before

Revenue: -2%accelerating
EPS: -71%

Price vs revenue and EPS, indexed to 100

Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends.

PriceRevenue, last 12 monthsEPS, last 12 months100 = first reading

EV/EBITDA at each year-end

The last weekly reading of each year, and its percentile against the five years before it.

OGN EV/EBITDA at each year-end
Year-end	EV/EBITDA	5-year percentile
Dec 29, 2025	7.4×	3
Dec 30, 2024	8.4×	13
Dec 25, 2023	9.1×	78
Dec 26, 2022	8.8×	71

Health Care peers on EV/EBITDA

Each percentile compares a stock with its own last five years.

Compare OGN with peers

Health Care peers of OGN on EV/EBITDA
Stock	EV/EBITDA	Versus its own history	5-year percentile
AXSMAxsome Therapeutics Inc	n/a	Not ranked	n/a, not ranked
BMYBristol Myers Squibb	9.6×	Within its usual range	45
CORTCorcept Therapeutics Inc	n/a	Not ranked	n/a, not ranked
ELANElanco Animal Health Inc	n/a	Not ranked	n/a, not ranked
JAZZJazz Pharmaceuticals PLC	10.9×	Below its usual range	29

Appears in

Sector: Health Care
Screens: Stocks with Low P/E Ratios and Steady Revenue Growth
Stocks Below Their 5-Year Median P/E
Stocks Near Their Lowest P/E Ratios in 5 Years

Screen Health Care stocks the same way

Research on OGN

No articles about OGN yet. How valuation percentiles work

Loading peers and related research…

About this history

What is OGN's current EV/EBITDA?: OGN's EV/EBITDA of 10.0x is higher than 88% of its weekly readings since May 2022.
What is OGN's five-year median EV/EBITDA?: 8.8x. Half of OGN's weekly readings since May 2022 were higher and half were lower. This page has 240 weekly readings, from Mar 21, 2022 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?: No. The rank compares OGN only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.